1. 2019
  2. In situ cell cycle analysis in giant cell tumor of bone reveals patients with elevated risk of reduced progression-free survival

    Maros E, M., Schnaidt, S., Balla, P., Kelemen, Z., Sapi, Z., Szendroi, M., Laszlo, T., Forsyth, R., Picci, P. & Krenacs, T., 21 Jun 2019, In : Bone. 127, p. 188-198 11 p.

    Research output: Contribution to journalArticleResearchpeer-review

  3. The anaphase-promoting complex/cyclosome: a new promising target in diffuse large B-cell lymphoma and mantle cell lymphoma

    Maes, A., Maes, K., De Raeve, H., De Smedt, E., Vlummens, P., Szablewski, V., Devin, J., Faict, S., De Veirman, K., Menu, E., Offner, F., Spaargaren, M., Moreaux, J., Vanderkerken, K., Van Valckenborgh, E. & De Bruyne, E., Jun 2019, In : British Journal of Cancer. 120, 12, p. 1137-1146 10 p.

    Research output: Contribution to journalArticleResearchpeer-review

  4. Terminal ileitis after kidney transplantation: Crohn's disease or other? Case reports and literature review

    Motté, E., Pipeleers, L., Wilgenhof, K., Reynaert, H., Urbain, D. & Mana, F., 20 Mar 2019, In : Acta Gastro-Enterologica Belgica. 82, 1, p. 63-66 4 p.

    Research output: Contribution to journalScientific reviewResearchpeer-review

  5. 2018
  6. Central diabetes insipidus: beware of Langerhans cell histiocytosis!

    Brys, A. D. H., Vermeersch, S., Forsyth, R., Velkeniers, B. & Bravenboer, B., Dec 2018, In : Netherlands Journal of Medicine. 76, 10, p. 445-449 5 p.

    Research output: Contribution to journalArticleResearchpeer-review

  7. Exosomes play a role in multiple myeloma bone disease and tumor development by targeting osteoclasts and osteoblasts

    Faict, S., Muller, J., De Veirman, K., De Bruyne, E., Maes, K., Vrancken, L., Heusschen, R., De Raeve, H., Schots, H., Vanderkerken, K., Caers, J. & Menu, E., 8 Nov 2018, In : Blood Cancer Journal. 8, 11, p. 105-105 1 p., 105.

    Research output: Contribution to journalArticleResearchpeer-review

  8. Un nouveau cas d’éruption de type pityriasis rubra pilaire associée à l’inhibiteur de tyrosine kinase ponatinib

    Krygier, J., Leemans, G., Forsyth, R., de Becker, A., Gutermuth, J. & Grosber, M., Nov 2018, In : Annales de dermatologie et de vénéréologie. 145, 11, p. 665-670 6 p.

    Research output: Contribution to journalArticleResearchpeer-review

  9. Focal radiation necrosis of the brain in patients with melanoma brain metastases treated with pembrolizumab

    Du Four, S., Jansen, Y., Michotte, A., Van Binst, A-M., Van den Begin, R., Duerinck, J. & Neyns, B., Oct 2018, In : Cancer Research. 7, 10, p. 4870-4879 10 p.

    Research output: Contribution to journalArticleResearchpeer-review

  10. Lymphoma-like monoclonal B cell lymphocytosis in a patient population: biology, natural evolution, and differences from CLL-like clones

    Vander Meeren, S., Heyrman, B., Renmans, W., Bakkus, M., Maes, B., De Raeve, H., Schots, R. & Jochmans, K., Jul 2018, In : Annals of Hematology. 97, 7, p. 1219-1227 9 p.

    Research output: Contribution to journalArticleResearchpeer-review

  11. Randomized phase II trial comparing axitinib with the combination of axitinib and lomustine in patients with recurrent glioblastoma

    Duerinck, J., Du Four, S., Bouttens, F., Andre, C., Verschaeve, V., Van Fraeyenhove, F., Chaskis, C., D'Haene, N., Le Mercier, M., Rogiers, A., Michotte, A., Salmon, I. & Neyns, B., Jan 2018, In : Journal of Neuro-Oncology. 136, 1, p. 115-125 11 p.

    Research output: Contribution to journalArticleResearchpeer-review

  12. Targeting angiogenesis in multiple myeloma by the VEGF and HGF blocking DARPinprotein MP0250: a preclinical study

    Rao, L., De Veirman, K., Giannico, D., Saltarella, I., Desantis, V., Frassanito, M. A., Solimando, A. G., Ribatti, D., Prete, M., Harstrick, A., Fiedler, U., De Raeve, H., Racanelli, V., Vanderkerken, K. & Vacca, A., 2018, In : Oncotarget. 9, 17, p. 13366-13381 16 p.

    Research output: Contribution to journalArticleResearchpeer-review

Previous 1 2 3 4 5 6 7 8 ...18 Next

ID: 36387385